Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VENLAFAXINE HYDROCHLORIDE USP, with a corresponding US DMF Number 18734.
Remarkably, this DMF maintains an Active status since its submission on September 09, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 07, 2015, and payment made on April 08, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II